Agalimmune's Series A Round

Agalimmune raised a round of funding on November 26, 2013.

Agalimmune is a biopharmaceutical company with an innovative anti-cancer technology for the treatment of patients with solid tumors. The Company's vision is to harness the power of the cancer patient'…

Articles about Agalimmune's Series A Round: